Making use of PEG-MZF-NPs’ excellent magnetic response and effective temperature control, CD44-shRNA gene therapy, DDP chemotherapy, and magnetic thermotherapy were organically combined together to treat ovarian cancer in vitro and in vivo (Figure 1). The gene discussed is CD44; the disease is ovarian carcinoma.